tert-butylhydroperoxide has been researched along with Diabetes Mellitus, Gestational in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araújo, JR; Correia-Branco, A; Faria, A; Ferraz, T; Keating, E; Martel, F; Ramalho, C | 1 |
1 other study(ies) available for tert-butylhydroperoxide and Diabetes Mellitus, Gestational
| Article | Year |
|---|---|
A parallel increase in placental oxidative stress and antioxidant defenses occurs in pre-gestational type 1 but not gestational diabetes.
Topics: Adult; Biomarkers; Diabetes Mellitus, Type 1; Diabetes, Gestational; Drug Resistance; Female; Glutathione; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Humans; Malondialdehyde; Oxidants; Oxidation-Reduction; Oxidative Stress; Placenta; Pregnancy; Pregnancy in Diabetics; Protein Carbonylation; Term Birth; tert-Butylhydroperoxide; Up-Regulation | 2013 |